| Company/Division name | Vaxxinova US |
| Parent company | Vaxxinova GmbH |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2022 |
| Capital investment ($): | 20 |
| Country(ies) from which reshored: | Netherlands |
| City reshored to: | Willmar |
| State(s) reshored to: | MN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | veterinary vaccines |
| What domestic positive factors made reshoring more attractive? | Government Incentives |
| Government Incentive dollar amount: | $1.3 million grant from the state |
